If you've been looking into weight loss options lately, you've probably come across one name again and again: semaglutide. It's been called a major shift, a breakthrough, even a highly effective medication. But what actually is it? And could it be right for you?
Let's start with the basics.
What Is Semaglutide?
Semaglutide is the active ingredient in several FDA-approved medications, including Wegovy (for weight loss) and Ozempic (for type 2 diabetes). It belongs to a class of medications called GLP-1 receptor agonists, drugs that mimic a natural hormone your body already produces.
Think of it this way: your body naturally produces a hormone called GLP-1 that tells your brain, "I'm full, stop eating." But for many people, this natural signal isn't strong enough to maintain a healthy weight. Semaglutide amplifies that signal, making it more powerful and longer-lasting.
### Key Facts at a Glance
How Does Semaglutide Work?
Semaglutide works through three main mechanisms that make weight loss feel less like a battle and more like a natural process your body supports.
### 1. Appetite Suppression at the Brain Level Semaglutide travels through your bloodstream and crosses into your brain, where it activates receptors in the hypothalamus, your body's hunger control center. This reduces the intensity of hunger signals, making it easier to eat less without feeling deprived.
Many patients describe this as "food noise" disappearing. The constant thoughts about what to eat next, the cravings, the mental chatter, it quiets down significantly.
### 2. Slower Digestion The medication signals your stomach to empty more slowly. This means food stays with you longer, and you feel full and satisfied for hours after eating. Smaller portions suddenly feel like enough.
### 3. Better Blood Sugar Control Semaglutide helps your pancreas release insulin more effectively when your blood sugar rises. This smooths out the spikes and crashes that can trigger hunger, fatigue, and cravings.
Who Is Semaglutide For?
Semaglutide is approved for adults who meet specific clinical criteria. You may be a candidate if you have:
Your doctor will also consider your overall health history, current medications, and any medical conditions.
What Results Can You Expect?
The landmark STEP (Semaglutide Treatment Effect in People with Obesity) clinical trials provide the most reliable data:
Individual results vary based on genetics, lifestyle, medication adherence, and metabolic health. Results may vary.
How Is Semaglutide Taken?
Semaglutide is a once-weekly injection, administered in the abdomen, thigh, or upper arm using a tiny needle. Most patients describe it as barely noticeable. Treatment follows a gradual dose escalation schedule.
How to Get Started
1. Start a 2-minute medical assessment 2. Connect with a board-certified physician licensed in your state 3. Get a personalized treatment plan if approved 4. Receive your medication at your door 5. Ongoing support from your care team
A $20 medical consultation fee applies only if a licensed physician reviews and approves your treatment.
Ready to find out if semaglutide is right for you? Start your 2-minute medical assessment to connect with a licensed physician and get started.
This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication. Individual results may vary. Clinical data referenced from the STEP 1, 3, and 5 trials published in The New England Journal of Medicine.
<!-- related-2026-injected -->
Related 2026 guides
Frequently Asked Questions
What does semaglutide do for weight loss?
Semaglutide reduces appetite, slows gastric emptying, and reduces reward-driven eating signals in the brain. The combined effect is that most patients eat smaller portions without consciously trying to and experience reduced food cravings within the first 1 to 2 weeks. In the STEP-1 trial (NEJM 2021), adults on semaglutide 2.4 mg lost an average of 14.9% of body weight at week 68. Semaglutide also improves cardiometabolic markers including blood pressure, lipids, and A1c independent of weight reduction.
Who is semaglutide for?
Brand-name Wegovy (semaglutide 2.4 mg) is FDA-approved for chronic weight management in adults with body mass index 30 or higher, or 27 or higher with at least one weight-related condition (such as type 2 diabetes, hypertension, dyslipidemia, or obstructive sleep apnea). Ozempic and Rybelsus (also semaglutide) are FDA-approved for type 2 diabetes. A US-licensed physician makes the final eligibility determination based on full medical history, contraindications, and treatment goals.
How long do you take semaglutide?
Current clinical guidance treats obesity as a chronic disease and supports long-term semaglutide use for patients who tolerate it well and continue to benefit. The STEP-1 extension trial showed that patients who stopped semaglutide regained an average of two-thirds of their lost weight within one year off medication. Patients who reach goal weight commonly continue at a lower maintenance dose rather than stopping cold. The long-term decision is made between patient and physician based on response, side effects, and overall health.
What is the difference between Ozempic, Wegovy, and Rybelsus?
All three contain the same active ingredient: semaglutide. Ozempic is a weekly injection FDA-approved for type 2 diabetes at doses up to 2.0 mg. Wegovy is a weekly injection FDA-approved for chronic weight management at doses up to 2.4 mg. Rybelsus is a daily oral tablet FDA-approved for type 2 diabetes, with strict dosing requirements (empty stomach, less than 4 ounces of water, wait 30 minutes before food). All three are manufactured by Novo Nordisk.
How fast does semaglutide work for weight loss?
Appetite reduction often begins within the first 1 to 2 weeks. Measurable weight reduction typically starts by week 4 and accelerates between months 3 and 6 as the dose escalates. Average weight reduction in the STEP-1 trial reached 6% by week 12, 10% by week 28, and 14.9% by week 68. Real-world results vary by individual based on dose, adherence, diet, activity, sleep, and genetics. Patients who stop early commonly miss the largest portion of potential weight reduction.
All Majesta Health medical content is clinically reviewed before publication by US-licensed physicians affiliated with our clinical infrastructure partner, MD Integrations (MDI). Reviewers hold active state medical licenses, are board-certified in primary care or obesity medicine, and specialize in GLP-1 receptor agonist therapy for chronic weight management. MDI is LegitScript certified and SOC 2 Type II accredited.
- US-licensed physicians affiliated with our clinical partner MD Integrations (LegitScript certified, HIPAA, SOC 2 Type II, ISO certified)
- Board-certified in primary care and obesity medicine
- Active state medical licensure required for every prescribing clinician
- Active DEA registration where applicable (note: GLP-1 medications are not controlled substances)
- Telehealth practice across all 50 US states and DC through the MD Integrations Medical Services Organization
- Dispensing pharmacy partner: Belmar Pharma Solutions (LegitScript certified, NABP accredited, 503A and 503B compounding)